[1]
“PHARMACOLOGICAL TREATMENT FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) IN PEDIATRIC PATIENTS”, RECIMA21, vol. 4, no. 1, p. e412633, Jan. 2023, doi: 10.47820/recima21.v4i1.2633.